.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Farmers Insurance
Cerilliant
Chubb
Accenture
Dow
Moodys
UBS
Citi
Daiichi Sankyo

Generated: November 22, 2017

DrugPatentWatch Database Preview

CYCLESSA Drug Profile

« Back to Dashboard

What is the patent landscape for Cyclessa, and what generic Cyclessa alternatives are available?

Cyclessa is a drug marketed by Aspen Global Inc and is included in one NDA.

The generic ingredient in CYCLESSA is desogestrel; ethinyl estradiol. There are eight drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the desogestrel; ethinyl estradiol profile page.

Summary for CYCLESSA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aspen Global Inc
CYCLESSA
desogestrel; ethinyl estradiol
TABLET;ORAL-28021090-001Dec 20, 2000ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: CYCLESSA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Aspen Global Inc
CYCLESSA
desogestrel; ethinyl estradiol
TABLET;ORAL-28021090-001Dec 20, 2000► Subscribe► Subscribe
Aspen Global Inc
CYCLESSA
desogestrel; ethinyl estradiol
TABLET;ORAL-28021090-001Dec 20, 2000► Subscribe► Subscribe
Aspen Global Inc
CYCLESSA
desogestrel; ethinyl estradiol
TABLET;ORAL-28021090-001Dec 20, 2000► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Moodys
Citi
Mallinckrodt
Merck
Chubb
Baxter
Accenture
Fish and Richardson
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot